{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:01:02Z","timestamp":1785528062319,"version":"3.56.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27966-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:13:51Z","timestamp":1780049631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factors for hepatitis B virus infection among expectant mothers in Jirapa Municipality, Upper West Region, Ghana: a facility-based cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yeri","family":"Monica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"27966_CR1","unstructured":"Centers for Disease Control and Prevention (CDC). What is viral hepatitis?. Atlanta (GA); 2021 [cited 2022 Aug 13]. Available from: https:\/\/www.cdc.gov\/hepatitis\/abc\/index.htm"},{"key":"27966_CR2","unstructured":"Centers for Disease Control and Prevention (CDC). Global viral hepatitis: millions of people are affected.. 2019 [cited 2022 Jun 10]. pp. 1\u20133. Available from: https:\/\/www.cdc.gov\/hepatitis\/global\/index.htm"},{"key":"27966_CR3","unstructured":"Centers for Disease Control and Prevention (CDC). Fast facts on global hepatitis B. 2022 [cited 2022 Jun 14]. Available from: https:\/\/www.cdc.gov\/globalhealth\/immunization\/diseases\/hepatitis-b\/data\/fast-facts.html"},{"key":"27966_CR4","doi-asserted-by":"crossref","unstructured":"Freeland C, Racho R, Kamischke M, Moraras K, Wang E, Cohen C et al. Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment. J Patient-Reported Outcomes. 2021 Dec 1 [cited 2022 Jun 14];5(1):121. Available from: \/pmc\/articles\/PMC8581088\/.","DOI":"10.1186\/s41687-021-00398-8"},{"key":"27966_CR5","doi-asserted-by":"publisher","unstructured":"Yang S, Zhong L, Huang L, Lin S, Li Y. Global burden and trends of viral hepatitis among women of childbearing age from 1990 to 2021. Front Microbiol. 2025;16. https:\/\/doi.org\/10.3389\/fmicb.2025.1553129.","DOI":"10.3389\/fmicb.2025.1553129"},{"key":"27966_CR6","doi-asserted-by":"publisher","unstructured":"Sonderup MW, Spearman CW. Global disparities in hepatitis B elimination-a focus on Africa. Viruses. 2022;14(1). https:\/\/doi.org\/10.3390\/v14010082.","DOI":"10.3390\/v14010082"},{"issue":"5","key":"27966_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/hep.1840010502","volume":"1","author":"W Szmuness","year":"1981","unstructured":"Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): final report. Hepatology. Hepatology. 1981;1(5):377\u201385.","journal-title":"Hepatology"},{"key":"27966_CR8","unstructured":"World Health Organization (WHO). Guidelines on hepatitis B and C testing. Vol. 66, Guidelines on hepatitis B and C testing. Geneva (GA): WHO. 2017. 1\u2013170 p. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/254621"},{"key":"27966_CR9","unstructured":"Centers for Disease Control and Prevention (CDC). Principles of epidemiology: lesson 1, Sect.\u00a0 10. CDC. Atlanta (GA); 2020 [cited 2022 Jul 31]. Available from: https:\/\/www.cdc.gov\/csels\/dsepd\/ss1978\/lesson1\/section10.html"},{"issue":"2","key":"27966_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.33545\/surgicalnursing.2021.v3.i2a.67","volume":"3","author":"S Lakra","year":"2021","unstructured":"Lakra S. World hepatitis day: Hepatitis can\u2019t wait (28 July 2021). Int J Adv Res Med Surg Nurs. 2021;3(2):20\u20133.","journal-title":"Int J Adv Res Med Surg Nurs"},{"key":"27966_CR11","doi-asserted-by":"crossref","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018 Apr 1 [cited 2022 Jul 20];67(4):1560\u201399. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1007\/s10389-019-01061-w.","DOI":"10.1002\/hep.29800"},{"key":"27966_CR12","unstructured":"World Health Organization (WHO). Hepatitis B. 2022 [cited 2022 Jul 23]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"27966_CR13","unstructured":"Centers for Disease Control and Prevention (CDC). What is hepatitis B? FAQ | CDC. 2020 [cited 2022 Jul 21]. Available from: https:\/\/www.hepb.org\/what-is-hepatitis-b\/faqs\/what-is-hepatitis-b"},{"key":"27966_CR14","unstructured":"World Health Organization (WHO). Hepatitis: Preventing mother-to-child transmission of the hepatitis B virus. 2020 [cited 2022 Jul 31]. Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/hepatitis-preventing-mother-to-child-transmission-of-the-hepatitis-b-virus"},{"key":"27966_CR15","unstructured":"Navabakhsh B, Mehrabi N, Estakhri A, Mohamadnejad M, Poustchi H. Hepatitis B virus infection during pregnancy: transmission and prevention. Middle East J Dig Dis. 2011;3(2):92\u2013102. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25197539"},{"key":"27966_CR16","doi-asserted-by":"publisher","unstructured":"Dun-Dery F, Adokiya MN, Walana W, Yirkyio E, Ziem JB. Assessing the knowledge of expectant mothers on mother-to-child transmission of viral hepatitis B in Upper West region of Ghana. BMC Infect Dis. 2017;17(1). https:\/\/doi.org\/10.1186\/s12879-017-2490-x.","DOI":"10.1186\/s12879-017-2490-x"},{"issue":"9","key":"27966_CR17","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.4254\/wjh.v13.i9.1190","volume":"13","author":"G Mahamat","year":"2021","unstructured":"Mahamat G, Kenmoe S, Akazong EW, Ebogo-Belobo JT, Mbaga DS, Bowo-Ngandji A, et al. Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis. World J Hepatol. 2021;13(9):1190\u2013202.","journal-title":"World J Hepatol"},{"key":"27966_CR18","doi-asserted-by":"crossref","unstructured":"Ginzberg D, Wong RJ, Gish R, Global. HBV burden: guesstimates and facts. Hepatol Int 2018 124. 2018 Jul 27 [cited 2021 Sep 22];12(4):315\u201329. Available from: https:\/\/link.springer.com\/article\/10.1007\/s12072-018-9884-8.","DOI":"10.1007\/s12072-018-9884-8"},{"key":"27966_CR19","doi-asserted-by":"crossref","unstructured":"Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Vol. 2, Lancet Gastroenterology and Hepatology. 2017 [cited 2021 Dec 21]. p. 900. Available from: https:\/\/reader.elsevier.com\/reader\/sd\/pii\/S2468125317302959","DOI":"10.1016\/S2468-1253(17)30295-9"},{"key":"27966_CR20","doi-asserted-by":"crossref","unstructured":"Ofori-Asenso R, Agyeman AA. Hepatitis B in Ghana: a systematic review and meta-analysis of prevalence studies (1995\u20132015). BMC Infect Dis. 2016 Mar 18 [cited 2021 Dec 30];16(1):1\u201315. Available from: https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1467-5.","DOI":"10.1186\/s12879-016-1467-5"},{"key":"27966_CR21","unstructured":"World Health Organization (WHO). Global Health Sector Strategy on viral hepatitis 2016\u20132021 towards ending viral hepatitis. 2016."},{"key":"27966_CR22","unstructured":"World Health Organization (WHO). Combating hepatitis B and C to reach elimination by 2030: advocacy brief. WHO. 2016 [cited 2022 Aug 16];1\u201317. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/206453"},{"key":"27966_CR23","doi-asserted-by":"crossref","unstructured":"Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C et al. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus. BMC Infect Dis. 2016. https:\/\/stacks.cdc.gov\/view\/cdc\/41142\/cdc_41142_DS1.pdf.","DOI":"10.1186\/s12879-016-1734-5"},{"key":"27966_CR24","unstructured":"Adade R. Prevalence of hepatitis B among pregnant women in Ghana. UG, Accra. 2021; Available from: http:\/\/197.255.68.203\/handle\/123456789\/21775."},{"key":"27966_CR25","doi-asserted-by":"publisher","unstructured":"Awiah EA, Aabalekuu S, Dun-Dery F, Dun-Dery E, Bayor F, Adokiya MN et al. Correlates of hepatitis B infection in pregnant women attending antenatal clinics in Wa Municipality, Ghana. PLOS Glob Public Heal. 2024;4(9):1\u201313. Available from: https:\/\/doi.org\/10.1371\/journal.pgph.0002447","DOI":"10.1371\/journal.pgph.0002447"},{"key":"27966_CR26","unstructured":"GHS. Jirapa Municipal Health Directorate: 2024 annual health performance report.. 2025. Available from: Ghana Health Service - Upper West Region Reports."},{"key":"27966_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/3157202","volume":"2023","author":"ED Kuugbee","year":"2023","unstructured":"Kuugbee ED, Maaldu G, Adamu A, Salia N, Walana W, Kampo S, et al. Seroprevalence and risk factors of sexually transmitted blood-borne infections among pregnant women attending antenatal care in Jirapa, Upper West Region of Ghana. Can J Infect Dis Med Microbiol. 2023;2023:1\u20139.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"27966_CR28","doi-asserted-by":"publisher","unstructured":"Tuck C, Rashid A, Iddrisu T, Moro SA, Akparibo R, Aryeetey R et al. A public health call for action to address liver cancer and hepatitis in northern Ghana. Commun Med. 2025;1\u20132. Available from: https:\/\/doi.org\/10.1038\/s43856-025-00854-2","DOI":"10.1038\/s43856-025-00854-2"},{"key":"27966_CR29","unstructured":"Alvarez CI. Study area map generator: an online tool for creating maps for scientific publications. 2023 [cited 2026 Jan 16]. Available from: https:\/\/cesarivanalvarez.shinyapps.io\/country-map\/"},{"key":"27966_CR30","unstructured":"Ghana Statistical Service (GSS). Jirapa Municipal - population statistics, charts, map and location. 2021 [cited 2021 Dec 17]. Available from: https:\/\/www.citypopulation.de\/en\/ghana\/admin\/upper_west\/1006__jirapa_municipal\/"},{"key":"27966_CR31","unstructured":"Ghana Statistiscal Services (GSS). 2022\u20132025 medium term development plan (MTDP), Jirapa. 2022."},{"key":"27966_CR32","volume-title":"2022 health sector annual programme of work: holistic assessment report","author":"Ministry of Health (MOH)","year":"2022","unstructured":"Ministry of Health (MOH). 2022 health sector annual programme of work: holistic assessment report. Ghana: Accra; 2022."},{"key":"27966_CR33","unstructured":"Cochran WG. Sampling techniques. 2nd ed. New York: Wiley; In 1963."},{"key":"27966_CR34","doi-asserted-by":"publisher","unstructured":"Ekouevi DK, Larrouy L, Gbeasor-Komlanvi FA, Mackiewicz V, Tchankoni MK, Bitty-Anderson AM et al. Prevalence of hepatitis B among childbearing women and infant born to HBV-positive mothers in Togo. BMC Infect Dis. 2020;20(1). https:\/\/doi.org\/10.1186\/s12879-020-05574-7.","DOI":"10.1186\/s12879-020-05574-7"},{"key":"27966_CR35","doi-asserted-by":"crossref","unstructured":"Abesig J, Chen Y, Wang H, Mwekele F, Irene S, Wu XY. Prevalence of viral hepatitis B in Ghana between 2015 and 2019: a systematic review and meta-analysis. PLoS One. 2020 Jun 1 [cited 2022 Mar 29];15(6):e0234348. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0234348","DOI":"10.1371\/journal.pone.0234348"},{"key":"27966_CR36","doi-asserted-by":"crossref","unstructured":"Cho Y, Bonsu G, Akoto-Ampaw A, Nkrumah-Mills G, Nimo JJA, Park JK et al. The prevalence and risk factors for hepatitis B surface ag positivity in pregnant women in Eastern Region of Ghana. pubmed. 2012.","DOI":"10.5009\/gnl.2012.6.2.235"},{"issue":"6","key":"27966_CR37","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4269\/ajtmh.17-0752","volume":"99","author":"CA Adjei","year":"2018","unstructured":"Adjei CA, Atibila F, Apiribu F, Ahordzor F, Attafuah PA, Ansah-nyarko M, et al. Hepatitis B infection among parturient women in peri-urban Ghana. J Trop Med Hyg. 2018;99(6):1469\u201374.","journal-title":"J Trop Med Hyg"},{"key":"27966_CR38","doi-asserted-by":"publisher","unstructured":"Kwadzokpui PK, Akorsu EE, Abaka-Yawson A, Quarshie SS, Amankwah SA, Tawiah PA. Prevalence and knowledge of hepatitis b virus infection among pregnant women in the Ningo-Prampram District, Ghana. Int J Hepatol Int J Hepatol. 2020. https:\/\/doi.org\/10.1155\/2020\/7965146.","DOI":"10.1155\/2020\/7965146"},{"key":"27966_CR39","unstructured":"Adebayo O, Adetunji AA, Oluwaseun E. Hepatitis B virus seroprevalence and its determinants among pregnant women in West Africa: A systematic review. J Public Heal. 2020 Available from: https:\/\/link.springer.com\/article\/10.1007\/s10389-019-01061-w."},{"key":"27966_CR40","doi-asserted-by":"publisher","unstructured":"Anaba EA, Dortey BA, Lassey AT, Damale NKR, Maya ET. Seroprevalence-of-hepatitis-B-virus-infection-and-ass-virus-infection-and-associated-factors-among-pregnant-women-at-KorleBu-Teaching-Hospital-Ghana. PLoS-ONE. 2020;15(4). https:\/\/doi.org\/10.1371\/journal.pone.0232208.","DOI":"10.1371\/journal.pone.0232208"},{"key":"27966_CR41","first-page":"24","volume":"2","author":"I Nsiah","year":"2020","unstructured":"Nsiah I, Danquah CB, Anto EO, Obirikorang C, Owiredu WKBA, Acheampong E, et al. Factors associated with knowledge, attitude, and practice towards hepatitis B infection among pregnant women attending antenatal clinic in the Kumasi Metropolis, Ghana: a multi-centre hospitalbased cross-sectional study. Pan Afr Med J One Heal. 2020;2:24.","journal-title":"Pan Afr Med J One Heal"},{"key":"27966_CR42","doi-asserted-by":"publisher","unstructured":"Mkandawire P, Atuoye KN, Armah FA, McLeod R, Luginaah I. The syndemic of infectious diseases and socio-economic deprivation in Northern Ghana. (Published as: Assessing the impacts of socio-economic and environmental factors on the syndemic of infectious diseases in Northern Ghana.). Heal place. 2023;Volume 79,. Available from: https:\/\/doi.org\/10.1016\/j.healthplace.2022.102967","DOI":"10.1016\/j.healthplace.2022.102967"},{"key":"27966_CR43","doi-asserted-by":"crossref","unstructured":"Hambridge T, Nartey YA, Duah A, Plymoth A. Hepatitis B mother-to-child transmission in the Eastern Region of Ghana: a cross-sectional pilot study. Pan Afr Med J. 2019;8688:33(218). Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6814340\/","DOI":"10.11604\/pamj.2019.33.218.17242"},{"key":"27966_CR44","doi-asserted-by":"publisher","unstructured":"Eduku A, Senoo-dogbey VE. Seroprevalence of hepatitis B virus infection (HBsAg) and associated factors among antenatal clinic attendees in a secondary-level facility in southern Ghana. Clin Epidemiol Glob Heal. 2024;26(September 2023):101553. Available from: https:\/\/doi.org\/10.1016\/j.cegh.2024.101553","DOI":"10.1016\/j.cegh.2024.101553"},{"key":"27966_CR45","doi-asserted-by":"publisher","unstructured":"Mutaru AM, Tijani A, Martin B, Adokiya N. Socio\u2013demographic determinants of hepatitis B virus seropositivity among adults in Tolon, Ghana: a community\u2013based survey. Discov Viruses. 2025 Available from: https:\/\/doi.org\/10.1007\/s44370-025-00016-x","DOI":"10.1007\/s44370-025-00016-x"},{"key":"27966_CR46","unstructured":"World Health Organization (WHO). Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.. WHO. Geneva. 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240090903"},{"key":"27966_CR47","unstructured":"Ministry of Health (MOH). National guidelines for prevention, care and treatment for viral hepatitis. Ghana. Ghana; 2024."},{"key":"27966_CR48","doi-asserted-by":"publisher","unstructured":"Etti M, Davies HG, Amone A, Kyohere M, Tusubira V, Burt J et al. Antenatal Screening for Hepatitis B Virus in Uganda: Missed Opportunities for Diagnosis and Treatment. Open Forum Infect Dis. 2024;11(Suppl 3):193\u20139. Available from: https:\/\/doi.org\/10.1093\/ofid\/ofae603","DOI":"10.1093\/ofid\/ofae603"},{"key":"27966_CR49","doi-asserted-by":"publisher","unstructured":"Duri K, Munjoma PT, Mataramvura H, Mazhandu AJ. Antenatal hepatitis B virus sero \u2013 prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting. BMC Infect Dis. 2023;1\u201317. Available from: https:\/\/doi.org\/10.1186\/s12879-023-08523-2","DOI":"10.1186\/s12879-023-08523-2"},{"key":"27966_CR50","doi-asserted-by":"crossref","unstructured":"Belete D, Fekadie E, Kassaw M, Fenta M, Jegnie A, Mulu T. Seroprevalence of hepatitis B virus and hepatitis C virus infection among pregnant women attending antenatal care at Guhala Primary Hospital, Northwestern. 2024;1\u20137.","DOI":"10.1186\/s12884-024-06714-6"},{"key":"27966_CR51","doi-asserted-by":"crossref","unstructured":"Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. To die is better than to tell: reasons for and against disclosure of chronic hepatitis B status in Ghana. BMC Public Health. 2020 May 12 [cited 2022 Jul 20];20(1):1\u20139. Available from: https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-08811-5.","DOI":"10.1186\/s12889-020-08811-5"},{"key":"27966_CR52","first-page":"1","volume":"22","author":"MT Frempong","year":"2019","unstructured":"Frempong MT, Ntiamoah P, Id MEA, akollor, William KB, Owiredu A, Addai-mensah O, et al. Hepatitis B and C infections in HIV and non-HIV infected pregnant women in the Brong-Ahafo Region. Ghana. 2019;22:1\u201313.","journal-title":"Ghana"},{"key":"27966_CR53","doi-asserted-by":"publisher","unstructured":"Wondmeneh TG, Mekonnen AT. Epidemiology of hepatitis B virus infection among pregnant women in Africa: a systematic review and meta\u2013analysis. BMC Infect Dis. 2024; Available from: https:\/\/doi.org\/10.1186\/s12879-024-09839-3","DOI":"10.1186\/s12879-024-09839-3"},{"key":"27966_CR54","unstructured":"Razavi-Shearer D, Gamkrelidze I, Nguyen MH, Chen DS, Van Damme P, Abbas Z et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018 Jun 1 [cited 2022 Mar 31];3(6):383\u2013403. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29599078\/"},{"key":"27966_CR55","doi-asserted-by":"crossref","unstructured":"Kiros KG, Goyteom MH, Tesfamichael YA, Mekonen HH, Gebru TH, Gebrehiwot TG et al. Seroprevalence of hepatitis B virus infection, mother-to-child transmission, and associated risk factors among delivering mothers in Tigray Region, Northern Ethiopia: a cross-sectional study. Infect Dis. 2020 Dec 1 [cited 2022 Jul 28];9(4):901\u201311. Available from: https:\/\/link.springer.com\/10.1007\/s40121-020-00340-3.","DOI":"10.1007\/s40121-020-00340-3"},{"key":"27966_CR56","doi-asserted-by":"publisher","unstructured":"Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. The status of hepatitis B control in the African region. Pan Afr Med J. 2017;27. https:\/\/doi.org\/10.11604\/pamj.supp.2017.27.3.11981.","DOI":"10.11604\/pamj.supp.2017.27.3.11981"},{"key":"27966_CR57","doi-asserted-by":"crossref","unstructured":"Bigna JJ, Kenne AM, Hamroun A, Ndangang MS, Foka AJ, Tounouga DN et al. Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis. Infect Dis Poverty. 2019 Mar 4 [cited 2022 Mar 31];8(1):1\u201312. Available from: https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-019-0526-8.","DOI":"10.1186\/s40249-019-0526-8"},{"key":"27966_CR58","doi-asserted-by":"crossref","unstructured":"Umer A, Teklemariam Z, Ayele F, Mengesha M. Prevalence of hepatitis B infection and its associated factors among pregnant mothers attending antenatal care at public hospitals at Hararghe, Eastern Ethiopia. Front Glob Women\u2019s Heal; 2023. pp. 1\u201311. April.","DOI":"10.3389\/fgwh.2023.1056488"},{"key":"27966_CR59","doi-asserted-by":"publisher","unstructured":"Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007. https:\/\/doi.org\/10.1111\/j.1872-034X.2007.00098.x.","DOI":"10.1111\/j.1872-034X.2007.00098.x"},{"key":"27966_CR60","doi-asserted-by":"crossref","unstructured":"Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia : a cross sectional study. BMC Infect Dis. 2014;1\u20137.","DOI":"10.1186\/1471-2334-14-118"},{"key":"27966_CR61","doi-asserted-by":"crossref","unstructured":"Abdulai MA, Baiden F, Adjei G, Owusu-Agyei S. Low level of hepatitis B knowledge and awareness among pregnant women in the Kintampo North Municipality: implications for effective disease control in Ghana. Ghana Med J. 2016 Oct 12 [cited 2022 Apr 30];50(3):157\u201362. Available from: https:\/\/www.ajol.info\/index.php\/gmj\/article\/view\/145768","DOI":"10.4314\/gmj.v50i3.7"},{"key":"27966_CR62","doi-asserted-by":"crossref","unstructured":"Bardoe D, Hayford D, Bagngmen R, Yar DD. Prevalence and correlates of hepatitis B in pregnancy:evidence from a cross-sectional study in Bono East Region, Ghana. 2025;1\u201313.","DOI":"10.1002\/hsr2.71263"},{"key":"27966_CR63","doi-asserted-by":"publisher","unstructured":"Mbim EN, Mboto CI, Agbo BE. Nosocomial infections in Sub-Saharan Africa. 2024; Available from: https:\/\/doi.org\/10.9734\/BPI\/RABR\/V3.","DOI":"10.9734\/BPI\/RABR\/V3"},{"key":"27966_CR64","unstructured":"World Health Organization (WHO). Guidelines for the prevention of mother-to-child transmission of HBV: Ghana country report. 2024."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27966-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27966-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27966-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:17:24Z","timestamp":1785521844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27966-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27966"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27966-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical oversight and introductory approval for this study were granted by the Department of Epidemiology and Biostatistics, School of Public Health, Kwame Nkrumah University of Science and Technology (KNUST), under reference number SPH\/EB\/RAI\/Vol.1. Administrative permission to conduct the study and access participants and facility records was obtained from the Ghana Health Service through the Jirapa Municipal Health Directorate (reference number GHS\/JMHD\/DT\/F-). The study was conducted in accordance with the ethical principles of the Declaration of Helsinki for research involving human participants. Prior to enrollment, all participants were provided with a clear explanation of the study\u2019s objectives, risks, and benefits in their preferred local language. Participation was entirely voluntary, and all subjects provided written informed consent prior to taking part in the research. For illiterate participants, written informed consent was obtained by thumbprinting in the presence of an independent witness; therefore, no legally authorized representative was required. No personal identifiable information was collected, and all data were de-identified to protect participant privacy. While a formal protocol number was not issued by a central ethics committee, signed approval and introductory letters are on file and can be made available upon request from the corresponding author.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2238"}}